Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value
$298.47M
Total Bought
$80.27M
Total Sold
$16.69M
Net Transaction
+$63.59M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ARGENX SE(ARGX)149,977150,000+2382,670110,63437.07%+27,964
DISC MEDICINE INC(IRON)265,000430,000+165,00014,03428,4149.52%+14,380
REVOLUTION MEDICINES INC(RVMD)280,000492,300+212,30010,30122,9907.70%+12,689
CRINETICS PHARMACEUTICALS IN(CRNX)0260,000+260,000010,8293.63%+10,829
RHYTHM PHARMACEUTICALS INC(RYTM)1,060,000763,707-296,29366,98177,12725.84%+10,145
CORCEPT THERAPEUTICS INC(CORT)343,917392,331+48,41425,24432,60710.92%+7,363
STOKE THERAPEUTICS INC(STOK)0212,049+212,04904,9831.67%+4,983
CYTOKINETICS INC(CYTK)037,587+37,58702,0660.69%+2,066
SEPTERNA INC(SEPN)586,473283,158-303,3156,1995,3261.78%-873
KYMERA THERAPEUTICS INC(KYMR)106,99161,750-45,2414,6693,4951.17%-1,174
PROTAGONIST THERAPEUTICS INC81,3110-81,3114,4940—-4,494
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q3 2025 | TickerTrail